Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YA II Equities Fund is an investment fund managed by Yorkville Advisors Global, LP, a New Jersey-based investment firm. The fund specializes in providing customized debt and equity financing solutions, such as Standby Equity Purchase Agreements (SEPAs) and convertible debentures, to small and micro-cap publicly traded companies. It is a frequent financier for emerging companies in the biotechnology, pharmaceutical, and healthcare sectors, providing the capital necessary for clinical trials and operational growth. While the fund does not develop its own therapeutic pipeline, its activities are central to the capitalization of many early-to-mid-stage life science entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YA II Equities Fund.